Xiaoyan Lu, Bo Li, Shoujuan Yang, Shiwang Fan, Mengqi Li, Shujun Shi, Hongbao Liang, Yongchao Chu
Abstract: Background: Scorpion venom protein (SVP) possesses
potent analgesic activity but requires daily intramuscular injection, severely
compromising patient compliance. Transdermal delivery offers a painless
alternative, yet the stratum corneum limits macromolecular permeation. Objectives: This study aimed to develop a
silk fibroin (SF)-based dissolvable microneedle patch for transdermal delivery
of SVP, enabling prolonged analgesic effect following a single administration. Methods: Dissolvable microneedles were
fabricated using SF as a sustained-release matrix for needle tips and
polyacrylic acid (PAA) as a soluble backing layer. Microneedles were
characterized for morphology, mechanical strength, skin penetration ability and
backing dissolution time. Skin irritation was assessed in male Sprague-Dawley (SD) rats. Analgesic efficacy
was evaluated in male BALB/c mice using acetic acid-induced
writhing and tail-flick assays, comparing the microneedle patch with
intramuscular injection. Results: The
fabricated microneedles were conical, ~590 μm in length, enabling effective
penetration of mouse skin. The PAA backing dissolved completely within 5 min in
phosphate-buffered saline (PBS). No skin irritation (erythema or edema) was
observed. In the writhing test, the microneedle group showed inhibition rates
of 74.0% at 1 h and 72.4% at 4 h; by contrast, the injection group showed 69.1%
at 1 h but dropped sharply to 8.0% at 4 h. The tail-flick assay confirmed
prolonged analgesia with microneedle application. Conclusion: SVP-loaded SF-based dissolvable
microneedles are safe, provide sustained analgesic effects and represent a
promising alternative to frequent injections for chronic pain management

Dissolvable microneedle
Scorpion venom protein
Silk fibroin
Sustained analgesia
Transdermal delivery